Top Tweets for #ComplementPathway
🩸Facts about PNH & Breakthrough Hemolysis:
PIGA mutation leads to loss of CD55/CD59, driving complement-mediated intravascular hemolysis, thrombosis, and nitric oxide depletion symptoms.
#Hematology #PNH #ComplementPathway #ComplementSystem #RareDiseases #MedEd #HematologyEducation #ClinicalEducation #Pathophysiology #Immunology #Autoimmunity #Hemolysis #IntravascularHemolysis #ParoxysmalNocturnalHemoglobinuria #Thrombosis #BoneMarrowFailure #Dysphagia #HEMEHUB
Novo Nordisk acquires full global rights to zaltenibart, a MASP-3 inhibitor from Omeros, in a deal worth up to $2.1B.
Targets rare complement-driven diseases like PNH and IgAN — with Phase 3 trials set to begin soon.
🔗 https://t.co/wdsqFFHVGU
#RareDisease
#ComplementPathway
#MonoclonalAntibody
#IgG4 related disease (IgG4-RD) and a particular renal manifestation, with interesting pathophysiological implications
#glomerulonephritis #complementpathway
@KidneyMed
⬇️⬇️
🔗https://t.co/1xUXoEl3cU

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy
https://t.co/uvHixcht2G
#CIDP #Riliprubart #OrphanDrug #Sanofi #ComplementPathway #Neurology #AutoimmuneDisease #Immunotherapy #ClinicalTrials #MOBILIZE #VITALIZE #RareDisease
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
https://t.co/AS32IN7qMH
#C3G #RareDisease #KidneyDisease #Fabhalta #Iptacopan #Proteinuria #FDAapproval #ComplementPathway #Nephrology #Novartis
Advancing Biomarkers and Complement Inhibitors in aHUS:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology @aHUSUKvoice @ThrombosisCan @iuis_online @EuropeanTHA @hemolyticanemia @isth
@HTRStoday @HTRSFellows @ASNKidney @Kidney_Research @RareDiseases @rarediseasesnet
@rarediseaseuk
Clinical Implications in aHUS:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology @aHUSUKvoice @ThrombosisCan @iuis_online @EuropeanTHA @hemolyticanemia @isth
@HTRStoday @HTRSFellows @ASNKidney @Kidney_Research @RareDiseases @rarediseasesnet
@rarediseaseuk
Individualized C5 Inhibition in aHUS:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology @aHUSUKvoice @ThrombosisCan @iuis_online @EuropeanTHA @hemolyticanemia @isth
@HTRStoday @HTRSFellows @ASNKidney @Kidney_Research @RareDiseases @rarediseasesnet
@rarediseaseuk
Plasma Therapy and Immunosuppression in
aHUS:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology @aHUSUKvoice @ThrombosisCan @iuis_online @EuropeanTHA @hemolyticanemia @isth
@HTRStoday @HTRSFellows @ASNKidney @Kidney_Research @RareDiseases @rarediseasesnet
@rarediseaseuk
aHUS Treatment Options:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology @aHUSUKvoice @ThrombosisCan @iuis_online @EuropeanTHA @hemolyticanemia @isth
@HTRStoday @HTRSFellows @ASNKidney @Kidney_Research @RareDiseases @rarediseasesnet
@rarediseaseuk
Genetic and Biomarker Analysis in aHUS:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology @aHUSUKvoice @ThrombosisCan @iuis_online @EuropeanTHA @hemolyticanemia @isth
@HTRStoday @HTRSFellows @ASNKidney @Kidney_Research @RareDiseases @rarediseasesnet
@rarediseaseuk
Complement System Overview of aHUS:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology #HealthcareResearch #MedicalEducation #Diagnostics #Pathophysiology #AutoimmuneDisorders #BloodDisorders #RenalFailure #Thrombocytopenia #Anemia #Thrombosis
Components directly related to aHUS through the dysregulation of the alternative complement pathway:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology #HealthcareResearch #MedicalEducation #Diagnostics #Pathophysiology #AutoimmuneDisorders #BloodDisorders #RenalFailure #Thrombocytopenia #Anemia #Thrombosis
Complement regulation is crucial to preventing aHUS:
#aHUS #Hematology #Complement #ThromboticMicroangiopathy #EndothelialInjury #C3Convertase #RareDiseases #KidneyDisease #Microangiopathy #HematologyExperts #ComplementPathway #ClinicalHematology #Nephrology #HealthcareResearch #MedicalEducation #Diagnostics #Pathophysiology #AutoimmuneDisorders #BloodDisorders #RenalFailure #Thrombocytopenia #Anemia #Thrombosis
First‐in‐human study with SAR445088: A novel selective classical complement pathway inhibitor: https://t.co/bXYjnHtkpA #complement #complementpathway
For diseases like #aHUS the #complementpathway is 🔑 Ask us about functional/deposition assays to supplement soluble MAC (sC5b-9). Our suite of testing provides a 360-degree view of disease mechanisms to help diagnose patients and find participants for #clinicaltrials

The Alternate Pathway of the Complement System https://t.co/64fWdzyc2Z via @YouTube
#Medical #medicine #medicalnews #medicaleducation #medicinestudent #complementpathway #alternatepathway #immunity #immunology #immunologicaldiorder
We're sharing our expertise on #complementpathway #diagnostics w/ drug developers, uncovering important roles for the #immune system in #rarediseases & more common diseases. Talks include indications from #hematology & #oncology to #ophthalmology & #neurodegeneration.

Do you need a #centrallab for #clinicaltrials? Our CLIA lab tests for biomarkers related to #coagulation, #complementpathway & #platelet, providing 20 yrs of expertise. Reach out at #DIA2023 booth 914 or use the “CRO Inquiries” button in the link below ⬇️ https://t.co/8zyoQp159S

#ICYMI from Brandon L. Garcia @EastCarolina: Structural basis for classical #complementpathway inhibition by #LymeDisease spirochetes | #ReadTheJI #immunology #structuralimmunology 👉 https://t.co/MkOmgDKWZk

Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.1M followers

Barack Obama 
@barackobama
119.3M followers

Donald J. Trump 
@realdonaldtrump
111.6M followers

Cristiano Ronaldo 
@cristiano
108.8M followers

Narendra Modi 
@narendramodi
106.9M followers

Rihanna 
@rihanna
97.2M followers

NASA 
@nasa
92.1M followers

Justin Bieber 
@justinbieber
90.5M followers

KATY PERRY 
@katyperry
86.7M followers

Taylor Swift 
@taylorswift13
80.5M followers

Lady Gaga 
@ladygaga
72.1M followers

Kim Kardashian 
@kimkardashian
69.3M followers

YouTube 
@youtube
68.6M followers

Virat Kohli 
@imvkohli
68.4M followers

Bill Gates 
@billgates
63.4M followers

The Ellen Show
@theellenshow
62.5M followers

CNN 
@cnn
61.9M followers

Neymar Jr 
@neymarjr
61M followers

X 
@x
60.9M followers

CNN Breaking News 
@cnnbrk
59.9M followers






